期刊文献+

吴茱萸碱的合成及其结构表征和体内抗肿瘤作用 被引量:6

Synthesis as well as structural characterization and in vivo antitumor activity evaluation of evodiamine
下载PDF
导出
摘要 以色胺和N-甲基靛红酸酐作为起始原料合成了吴茱萸碱;利用元素分析仪、红外光谱仪、核磁共振谱仪、质谱仪等对合成产物进行了结构表征,并研究了其对小鼠移植性肉瘤S180和小鼠肝癌H22的体内抗肿瘤作用.结果表明,所合成的吴茱萸碱在高、中、低剂量(20 mg.kg-1、10 mg.kg-1、5 mg.kg-1)下均对S180和H22的生长具有抑制作用;同环磷酰胺相比,吴茱萸碱对脾脏和胸腺损伤较小,甚至具有一定的保护作用. Evodiamine was synthesized by using tryptamine and N-methylisatoic anhydride as the starting materials.The composition and structure of as-synthesized product were analyzed by means of elemental analysis,infrared spectrometry,1H-nuclear magnetic resonance spectroscopy,and mass spectrometry.The in vivo antitumor activity of evodiamine for S180 and H22 in mice was evaluated.Results showed that high,medium and low dose of evodiamine(20 mg · kg-1,10 mg · kg-1 and 5 mg · kg-1) could all effectively inhibit the growth of S180 and H22.In the meantime,as compared with cyclophosphamide,as-synthesized evodiamine had little damage to spleen and thymus,and even possessed protective effect.
出处 《化学研究》 CAS 2011年第3期22-25,共4页 Chemical Research
基金 国家自然科学基金青年基金项目(81001669) 陕西省教育厅专项科研计划项目(09JK393) 陕西中医学院中药制药重点学科资助课题
关键词 吴茱萸碱 合成 结构表征 体内抗肿瘤作用 evodiamine synthesis structure characterization in vivo antitumor activity
  • 相关文献

参考文献10

二级参考文献132

共引文献186

同被引文献38

  • 1杨秀丽,孙进,何仲贵.格列吡嗪油水分配系数和平衡溶解度的测定[J].中国药剂学杂志(网络版),2009(3):121-126. 被引量:30
  • 2国家药典委员会.中华人民共和药典(一部)[M].2010年版.北京:中国医药科技出版社,2010:160.
  • 3YU H,JIN H J, GONG W Z, et al. Pharmacological actions of multi-target-directed evodiamine [ J ]. Molecules, 2013, 18 ( 2 ): 1826-1843.
  • 4KO H C,WANG Y H, LIOU K T, et al. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioaetive components on neutrophils and microglial cells[J]. European Journal of Pharmacology,2007,555(2-3) :211-217.
  • 5SHIN Y W,BAE E A,CAI X F,et al. In vitro and in vivo antial- lergic effects on the fruits of Evodia rutaecarpa and its constitu- ents[J]. Biological Pharmaceutical Bulletin, 2007,30 : 197-199.
  • 6YANG J,CAI X T, LU W G, et al. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma ceils[J]. Cancer Letters, 2013,328 : 243-251.
  • 7SONG S C,CHEN Z Y,Li S X,et al. Design,synthesis and evalu- ation of N13-substituted evodiamine derivatives against human cancer cell lines[J]. Molecules, 2013,18 :15750-15768.
  • 8WANG K L,HSIA S M,YEH J Y,et al. Anti-proliferative effects of evodiamine on human breast cancer cells[J]. Public Library of Science,2013,8(6) :e67297.
  • 9CHRISTODOULOUA M S, SACCHETTI A, RONCHETTI V, et al. Quinazolinecarboline alkaloid evodiamine as scaffold for targe- ting topoisomerase I and sirtuins [ J ]. Bioorganic & Medicinal Chemistry,2013,21,6920-6928.
  • 10FURUKAWA S. In vitro chemosensitivity of hepatocellular carci- noma for hepatic arterial infusion chemotherapy using the MTT assay with the combinations of antiturnor drugs[J]. Kurume Med J,2004,51(1), 25-33.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部